Create a narrative

Inventiva Community

ENXTPA:IVA Community

1 Narratives written by author
0 Comments on narratives written by author
5 Fair Values set on narratives written by author

Create a narrative

AN

AnalystConsensusTarget

Consensus Narrative from 5 Analysts

Phase III Trials Will Advance Lanifibranor For MASH Treatment

Key Takeaways Strategic focus on lanifibranor development, cutting other activities, and reducing workforce may improve net margins through operational efficiency. Key partnerships in Asia and financial strength ensure market penetration and support sustained investment, boosting future earnings potential.

€6.30

FV

56.3% undervalued

-0.52%

Revenue growth p.a.

0

0

5

6 days ago